Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Fujifilm Corporation has agreed to invest JYP 100 million ($918 million) into Cuorips, a Tokyo-based start-up company developing regenerative medicines for treating heart failure, through underwriting a third-party allocation of shares. It also...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Evonik, Fujifilm Diosynth Biotechnologies, and Kaneka. Biologics Manufacturing Fujifilm To Produce Antigen for Novavax’s COVID-19 Vaccine Fujifilm Diosynth Biotechnologies, a...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Avid Bioservices and Abzena. Biologics Manufacturing Avid Bioservices, Humanigen in Mfg Pact for COVID-19 TherapeuticAvid Bioservices, a biologics CDMO, and Humanigen, a...

Lonza has agreed to sell its Specialty Ingredients business and operations to Bain Capital and Cinven, two private-equity firms, for an enterprise value of CHF 4.2 billion ($4.7 billion). Lonza’s Specialty Ingredients business provides microbial...

WuXi STA, a subsidiary of WuXi AppTec, has agreed to purchase Bristol-Myers Squibb’s manufacturing facility in Couvet, Switzerland. The facility has commercial-scale production capacity for capsule and tablet dosage forms. The companies anticipate...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Emergent BioSolutions, Ajinomoto Bio-Pharma Services, and Just–Evotec. Biologics Manufacturing Just–Evotec Expands US Gov’t Contract for Mfg of mAbs for COVID-19 Just–Evotec...